Teleflex Incorporated (TFX)

Market Cap	8.22B
Revenue (ttm)	3.03B
Net Income (ttm)	237.44M
Shares Out	46.44M
EPS (ttm)	5.03
PE Ratio	35.12
Forward PE	11.82
Dividend	$1.36 (0.77%)
Ex-Dividend Date	Nov 15, 2024

Volume	83,215
Open	178.18
Previous Close	179.51
Day's Range	175.27 - 178.50
52-Week Range	171.69 - 256.85
Beta	1.15
Analysts	Buy
Price Target	255.14 (+44.1%)
Earnings Date	Feb 20, 2025

About TFX

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional prod...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1943
• Employees: 14,500
• Stock Exchange: NYSE
• Ticker Symbol: TFX
• Website: https://www.teleflex.com

Financial Performance

In 2023, Teleflex's revenue was $2.97 billion, an increase of 6.57% compared to the previous year's $2.79 billion. Earnings were $356.33 million, a decrease of -1.88%.

Analyst Forecast

According to 8 analysts, the average rating for TFX stock is "Buy." The 12-month stock price forecast is $255.14, which is an increase of 44.10% from the latest price.

Price Target

$255.14

(44.10% upside)

Analyst Consensus: Buy